Unknown

Dataset Information

0

LAG-3: a very singular immune checkpoint.

ABSTRACT:

SUBMITTER: Lui Y 

PROVIDER: S-EPMC7612985 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

LAG-3: a very singular immune checkpoint.

Lui Yuan Y   Davis Simon J SJ  

Nature immunology 20181201 12

Similar Datasets

Unknown Progress of immune checkpoint LAG-3 in immunotherapy.
| S-EPMC7491111 | biostudies-literature
Unknown Relatlimab: a novel drug targeting immune checkpoint LAG-3 in melanoma therapy
| S-EPMC10806167 | biostudies-literature
Unknown The promising immune checkpoint LAG-3: from tumor microenvironment to cancer immunotherapy.
| S-EPMC6305110 | biostudies-literature
Unknown LAG-3 Inhibitors: Novel Immune Checkpoint Inhibitors Changing the Landscape of Immunotherapy.
| S-EPMC10377063 | biostudies-literature
Unknown Dissociation of LAG-3 inhibitory cluster from TCR microcluster by immune checkpoint blockade.
| S-EPMC11371725 | biostudies-literature
Unknown The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application.
| S-EPMC9361790 | biostudies-literature
Unknown LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade.
| S-EPMC9254663 | biostudies-literature
Unknown Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use.
| S-EPMC6843898 | biostudies-literature
Unknown From Virtual Screens to Cellular Target Engagement: New Small Molecule Ligands for the Immune Checkpoint LAG-3.
| S-EPMC11571005 | biostudies-literature
Unknown A Case of Lung Cancer with Very-Late-Onset Immune Checkpoint Inhibitor-Related Myocarditis.
| S-EPMC9294991 | biostudies-literature